The RealReal delivered a brutal post-earnings session on May 8, dropping 17% to $10.26, capping a week that saw the stock shed nearly 13% in total. The move crystallises the bear case: a still-material short base, a sharp analyst price target reset, and an earnings print that gave longs little to stand behind.
The short side of the book carries genuine weight here. SI % of free float ran at approximately 15.7% as of May 7, down from a peak near 18.7% in late April — that earlier pop coincided with the lead-up to earnings, and has since partially uncoiled. Notably, the April spike to nearly 18.7% FF reversed sharply around April 23-24, suggesting a wave of short covering after the setup was in place. Cost to borrow remains remarkably low at 0.43% annualised, down about 16% over the past month, meaning the borrow market is neither squeezing nor signalling any particular urgency from shorts. The ORTEX short score of 63.9 is elevated but has drifted off its recent peak near 65, consistent with a position that is large but not building.
Options traders offered no real warning of the disaster ahead. The put/call ratio at 0.27 is almost exactly in line with its 20-day average of 0.26 — flat, with a z-score barely above zero. The 52-week high on that ratio is 1.47, which shows the stock can attract serious hedging activity; none of that fear is present now. The call-heavy skew looks more like structural options writing or a bullish residual lean than active hedging — which, in hindsight, underscores how badly the earnings print was mispriced.
The Street took the results hard. UBS cut its target from $16 to $14 Friday while staying Neutral, and BTIG — the most persistently bullish house on the name — trimmed from $18 to $17 while holding its Buy. Both moves landed on May 8, the day after the print. The consensus mean target now sits at $17.25, nearly 68% above Friday's close of $10.26, a gap that reflects genuine disagreement rather than an obvious data artefact. Baird and KeyBanc remain Neutral and Overweight respectively, though their targets of $16 and $20 were set in February and January and look stale against the new tape. The bull case cites record active buyer growth — over one million active buyers, the largest sequential gain since Q4 2022 — and improving EBITDA margins. The bear case is more pointed: a potential 10-15% revenue shortfall versus estimates, consignor base stagnation, and macro headwinds to discretionary luxury spending.
FMR (Fidelity) is now the largest institutional holder with just over 10% of shares, having added nearly 12 million shares in the most recent filing period — a substantial accumulation. BlackRock and Vanguard sit at 7.3% and 5.3% respectively, with smaller incremental additions. Insider activity tells a subtler story. The CFO sold around 51,600 shares at $9.29 in mid-March, and CEO Rati Sahi Levesque sold roughly 70,000 shares in late February at $10.72. None of the values are large in absolute terms, and a modest net-positive share figure over 90 days (around 287,000 shares) obscures the underlying direction, which has been broadly sell-side at the exec level.
The EPS momentum factor scores are striking — 97th and 98th percentile on 30-day and 90-day measures, and a 95th-percentile EPS surprise rank — which tells you the company has been consistently beating estimates. The paradox is that a strong beat on the headline numbers did not prevent a 21% single-day decline on May 7. The next earnings event is slated for June 10. The question heading into that print is whether the gap between a $10.26 stock and a $17+ consensus target narrows through fundamental re-acceleration, or whether the Street progressively capitulates toward the tape.
See the live data behind this article on ORTEX.
Open REAL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
